Newron Pharmaceuticals S.p.A. (LON:0QOI)
London · Delayed Price · Currency is GBP · Price in CHF 19.86
+0.53 (2.75%)
Feb 12, 2026, 3:02 PM GMT
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 372.16 million as of February 12, 2026. Its market cap has increased by 128.91% in one year.
Market Cap
372.16M
Enterprise Value
380.51M
Revenue
51.33M
Ranking
n/a
PE Ratio
17.14
Stock Price
19.86
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 130.73M to 372.16M, an increase of 184.69%. That is a compound annual growth rate of 5.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 372.16M | -16.73% |
| Dec 30, 2025 | 446.94M | 191.28% |
| Dec 30, 2024 | 153.44M | 86.31% |
| Dec 29, 2023 | 82.36M | 231.73% |
| Dec 30, 2022 | 24.83M | 5.96% |
| Dec 30, 2021 | 23.43M | -26.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 11.10B |
| Allergy Therapeutics | 644.85M |
| Craneware | 520.81M |
| Advanced Medical Solutions Group | 466.09M |
| PureTech Health | 311.77M |